As a novel heat shock protein 90 inhibitor, AT-533 exhibits various biological activities in vitro, including anti-viral, anti-tumor and anti-inflammatory activities. Moreover, gel, gel dosage form of AT-533, has been suggested to have anti-keratitis herpes simplex virus type-1 infection-induced effects on the skin lesions animals. However, safety evaluation has, best our knowledge, not examine...